The molecular product is essentially identical across vendors
More specifically, GLP-1 RAs have been linked to increased bone formation markers, such as P1NP, osteocalcin, and bone-specific alkaline phosphatase, while simultaneously reducing bone resorption markers, like -CTX (10, 11, 12)
Preclinical and clinical data suggest that GLP-1 signaling can downregulate pro-inflammatory cytokines, such as TNF- and IL-6, inhibit NF-Bmediated inflammatory cascades, and reduce oxidative stress
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort, affecting more than 1 in 10 patients
doi:10.1080/08998280.2025.2456441
For cosmetic purposes, subcutaneous injection is recommended, for the treatment of the liver we recommend intramuscular injection or IV